Landmark Bio
BioTech/Drugs - Greater Boston, N/A, US
Landmark Bio Details
Formerly known as the new center for advanced biological innovation and manufacturing (or "CABIM"), Landmark Bio, PBLLC is a public benefit limited liability company that was formed to advance the development of transformative new medicines by translating today's cutting-edge research into tomorrow's breakthrough therapies. The cross-sector partnership harnesses world-leading expertise to accelerate fast-emerging and promising science, the challenges of which are daunting for any single institution to tackle alone. Board members include leaders from Harvard University, Massachusetts Institute of Technology (MIT), FUJIFILM Diosynth Biotechnologies (FDB), Cytiva, and Alexandria Real Estate Equities, Inc. Other collaborating institutions include Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, the Dana-Farber Cancer Institute, Massachusetts General Hospital, and the Massachusetts Life Sciences Center. For more information please contact: Elizabeth Kennedy, Chief of Staff, Landmark Bio at media@landmarkbio.com
Landmark Bio Technologies
Email Providers
Outlook
Load Balancers
Nginx
Tag Management
Google Tag Manager
Other
Microsoft Office 365
Hosting
Google Cloud Hosting
CSS and JavaScript Libraries
JQuery 2.1.1